Pegasys (peginterferon alfa-2a)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Pegasys (peginterferon alfa-2a), covering 2012-11-20 to 2016-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Grazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012) [Phase 2]